These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 15035437

  • 1. [Slow progress in therapy of breast carcinoma].
    Aumiller J.
    MMW Fortschr Med; 2004 Jan 22; 146(3-4):4-6, 8, 10. PubMed ID: 15035437
    [No Abstract] [Full Text] [Related]

  • 2. [Organ preserving treatment of breast cancer].
    Topuzov EG, Krasnozhon DA.
    Vestn Khir Im I I Grek; 2004 Jan 22; 163(3):99-102. PubMed ID: 15317177
    [No Abstract] [Full Text] [Related]

  • 3. [Current trends in the treatment of primary breast cancer].
    Letiagin VP.
    Vopr Onkol; 1998 Jan 22; 44(5):632-5. PubMed ID: 9884732
    [No Abstract] [Full Text] [Related]

  • 4. [Current status and perspective in treatment of breast cancer in elderly women].
    Zhang BN, Zhang HM.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 22; 30(3):161-4. PubMed ID: 18756927
    [No Abstract] [Full Text] [Related]

  • 5. Breast cancer (non-metastatic).
    Rodger A, Stebbing J, Thompson AM.
    Clin Evid; 2006 Jun 22; (15):2360-92. PubMed ID: 16973090
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of breast cancer.
    Zurrida S, Veronesi U.
    Ann Chir Gynaecol; 2000 Jun 22; 89(3):187-90. PubMed ID: 11079786
    [No Abstract] [Full Text] [Related]

  • 7. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
    Singh Ranger G.
    J Clin Pharm Ther; 2005 Aug 22; 30(4):313-7. PubMed ID: 15985044
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant use of endocrine therapy in breast cancer.
    Macaskill EJ, Dixon JM.
    Breast J; 2007 Aug 22; 13(3):243-50. PubMed ID: 17461898
    [Abstract] [Full Text] [Related]

  • 9. [Breast carcinoma in accessory gland: a case report].
    Sivelli R, Del Rio P, Arcuri MF, Corcione L.
    G Chir; 2002 May 22; 23(5):179-80. PubMed ID: 12228967
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH, Hayes DF.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract] [Full Text] [Related]

  • 16. [Current standards in the treatment of breast cancer].
    Zwiefel K, Janni W.
    Med Monatsschr Pharm; 2011 Aug 20; 34(8):280-88; quiz 289-90. PubMed ID: 21853882
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ductal carcinoma-in-situ.
    Wickerham DL.
    J Clin Oncol; 2001 Sep 15; 19(18 Suppl):98S-100S. PubMed ID: 11560982
    [No Abstract] [Full Text] [Related]

  • 19. [Breast neoplasms: predictive factors for endocrine therapy ].
    Hayashi S.
    Nihon Rinsho; 2007 Jun 28; 65 Suppl 6():148-53. PubMed ID: 17682151
    [No Abstract] [Full Text] [Related]

  • 20. Aromatase inhibitors in breast cancer: an overview.
    Altundag K, Ibrahim NK.
    Oncologist; 2006 Jun 28; 11(6):553-62. PubMed ID: 16794235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.